Literature DB >> 24919482

Carotid-femoral pulse wave velocity is negatively correlated with aortic diameter.

Marc A Bailey1, Jennifer M Davies2, Kathryn J Griffin1, Katherine I Bridge1, Anne B Johnson2, Soroush Sohrabi2, Paul D Baxter3, D Julian A Scott1.   

Abstract

Cardiovascular events pose significant morbidity and mortality burden to abdominal aortic aneurysm (AAA) patients. Arterial stiffness as measured by pulse wave velocity (PWV) is an independent predictor of cardiovascular risk. We investigated the relationship between aortic diameter and PWV. Consecutive patients with AAA were invited to participate. Patients completed a health questionnaire, received aortic ultrasound and carotid-femoral PWV (cfPWV) recordings with a Vicorder. Thirty patients were used for reproducibility assessment. A linear regression model was used to identify significant predictors of cfPWV. Observer variation was assessed using Bland and Altman analysis and the intraclass correlation coefficient. Three hundred and nine patients were included-148 with AAA and 161 controls. The mean difference for repeated cfPWV between observers was 0.11 ms(-1). cfPWV was positively correlated with age (r=0.24, P<0.001) and systolic blood pressure (r=0.29, P<0.001) and negatively correlated with aortic diameter (r=-0.15, P=0.008). There was no difference in cfPWV between AAA and control groups (9.75±2.3 ms(-1) vs. 9.55±2.3 ms(-1), P=0.43). Aortic diameter (P=0.003) and systolic blood pressure (P<0.001) were significant predictors of cfPWV independent of age, aspirin usage and a history of myocardial infarction. Patients with large AAA (>5 cm) had decreased cfPWV compared with patients with small AAA (P=0.02) or normal diameter aorta (P=0.02). Vicorder measurements of cfPWV are repeatable. cfPWV is negatively associated with infra-renal aortic diameter and reduced in large AAA. cfPWV is likely invalid for accurate arterial stiffness assessment in patients with AAA owing to the apparent confounding effect of aortic size.

Entities:  

Mesh:

Year:  2014        PMID: 24919482     DOI: 10.1038/hr.2014.101

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  6 in total

1.  Estimation of pulse wave velocity in patients with peripheral artery disease: a word of caution.

Authors:  Victor Aboyans; Ileana Desormais; Aida Oueslati; Philippe Lacroix
Journal:  Hypertens Res       Date:  2015-10-22       Impact factor: 3.872

2.  Response to Aboyans, et al.: Estimation of pulse wave velocity in patients with peripheral artery disease: a word of caution.

Authors:  Maksim Zagura; Jaak Kals; Kaido Paapstel; Martin Serg; Priit Kampus; Jaan Eha; Mihkel Zilmer
Journal:  Hypertens Res       Date:  2016-04-14       Impact factor: 3.872

3.  Estimating central blood pressure from aortic flow: development and assessment of algorithms.

Authors:  Jorge Mariscal-Harana; Peter H Charlton; Samuel Vennin; Jorge Aramburu; Mateusz Cezary Florkow; Arna van Engelen; Torben Schneider; Hubrecht de Bliek; Bram Ruijsink; Israel Valverde; Philipp Beerbaum; Heynric Grotenhuis; Marietta Charakida; Phil Chowienczyk; Spencer J Sherwin; Jordi Alastruey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-10-16       Impact factor: 4.733

4.  The positive correlation between brachial-ankle pulse wave velocity and aortic diameter in Chinese patients with diabetes.

Authors:  Liping Li; Wenhui Xie; Qingqing Li; Huashan Hong
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-07-27       Impact factor: 2.885

5.  Association of pulse wave velocity and intima-media thickness with cardiovascular risk factors in young adults.

Authors:  Marina Cecelja; Raja Sriswan; Bharati Kulkarni; Sanjay Kinra; Dorothea Nitsch
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-19       Impact factor: 2.885

6.  Increased arterial stiffness in males with abdominal aortic aneurysm.

Authors:  Ida Åström Malm; Rachel De Basso; Peter Blomstrand; Niclas Bjarnegård
Journal:  Clin Physiol Funct Imaging       Date:  2020-10-19       Impact factor: 2.273

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.